Medicis (MRX +1.3%) gains on positive comments out of Goldman earlier today. The firm says the...

|By:, SA News Editor

Medicis (MRX +1.3%) gains on positive comments out of Goldman earlier today. The firm says the company is one of the most likely M&A targets in its peer group, and notes that its growth potential is under appreciated. It reiterats a Buy rated with a $45 price target.